February 24, 2018 |
CUMC Researchers Identify Key Molecular Pathways Leading to Alzheimer's
August 20, 2013  | 

“Our findings suggest that both SV2A and RFN219 are candidate drug targets,” said Dr. Abeliovich. “What’s exciting to us is that these approaches may play a role in the development of drugs for the common non-familial form of Alzheimer’s disease. This has been an enormous challenge.”

 

Visit: Columbia University Medical Center

Page | 1 2 3 4
Suggested Articles